DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Glaucoma Market: Industry Analysis & Outlook (2017-2021)" report to their offering.
"Global Glaucoma Market: Industry Analysis & Outlook (2017-2021)" analyzes the development of this market, with focus on the US and OUS treatment market. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report. The four major players: Pfizer Inc., Novartis AG, Merck & Co., Inc. and Allergan Plc. are being profiled along with their key financials and strategies for growth. The report contains a comprehensive analysis of the global glaucoma market along with the study of the US market.
Though glaucoma cannot be cured completely, the disease progression can be controlled with the help of available treatments. There are three types of modalities available for treatment of glaucoma: Drugs, Laser and Invasive Surgery. Further, based upon the approaches employed for the medication, it can be segmented into two parts: PGA Medication and Non-PGA Medication. The PGA approach reduces IOP with the help of prostaglandin (PGA). The non-PGA medication can be further divided into four sub segments: Beta blockers, Alpha blockers, Carbonic anhydrase inhibitors (CAIs) and Combination Products.
Several factors such as rising prevalence of diabetes, growing geriatric population and rising health care expenditure along with increasing disposable income and growing obese population will drive the market growth in the next few years. Development of new drugs & devices and drug therapy focused upon IOP are the few notable market trends. However, high cost of treatment, severe side effects and hasty drug approval processes act as a major roadblock for the market growth.
Key Topics Covered:
2. Global Glaucoma Market
3. Regional Markets
4. Market Dynamics
5. Competitive Landscape
6. Company Profiles
- Allergan Plc.
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc.
For more information about this report visit http://www.researchandmarkets.com/research/xns9b6/global_glaucoma